The Effect of Different Dosing Schedules of Intravitreal Sirolimus, a Mammalian Target of Rapamycin (mTOR) Inhibitor, in the Treatment of Non-Infectious Uveitis (An American Ophthalmological Society Thesis)

PURPOSE: To determine if two different doses of intravitreal sirolimus, an mTOR inhibitor, can decrease inflammation and is safe in eyes with non-infectious posterior, intermediate, or panuveitis in the Sirolimus as a Therapeutic Approach UVEitis: Protocol-2 (SAVE-2) Study. METHODS: SAVE-2 is a pros...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Trans Am Ophthalmol Soc
Main Authors: Nguyen, Quan Dong, Sadiq, Mohammad Ali, Soliman, Mohamed Kamel, Agarwal, Aniruddha, Do, Diana V., Sepah, Yasir J.
Formato: Artigo
Idioma:Inglês
Publicado em: The American Ophthalmological Society 2016
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5012855/
https://ncbi.nlm.nih.gov/pubmed/27630374
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados